Lamotrigine is FDA-approved for “Maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes in patients treated for acute mood episodes with standard therapy.” The Prescribing Information for lamotrigine states that the target dose in adults is 200 mg (for patients not taking another medication that significantly alters the clearance of…